Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020

SELL
$1.44 - $3.95 $39,084 - $107,210
-27,142 Closed
0 $0
Q4 2019

Feb 26, 2020

BUY
$1.17 - $2.33 $31,756 - $63,240
27,142 New
27,142 $51,000

Others Institutions Holding SURF

About Surface Oncology, Inc.


  • Ticker SURF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,034,000
  • Description
  • Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...
More about SURF
Track This Portfolio

Track Pvg Asset Management Corp Portfolio

Follow Pvg Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pvg Asset Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Pvg Asset Management Corp with notifications on news.